Richard Barry

Richard Barry currently serves as the LSD & Metabolism Franchise Lead for the UK & Ireland at Chiesi Group, a position held since January 2024. Prior to this role, Richard was the Rare Diseases Manager for Chiesi UK from April 2021 to January 2024 and held various positions at Chugai Pharma Europe from 2013 to 2020, including Regional Business Manager for Haematology Oncology and National Contracts and Commercial Business Manager. Richard's early career included work as a Senior Hospital Sales Specialist in Immunology. Richard holds a degree in Physiology and Pharmacology from The University of Sheffield, earned between 1994 and 1997, and is recognized for strong cross-functional collaboration and leadership in high-performing teams within the healthcare sector.